Next Article in Journal
Constitutive Equations for Analyzing Stress Relaxation and Creep of Viscoelastic Materials Based on Standard Linear Solid Model Derived with Finite Loading Rate
Next Article in Special Issue
Pulmonary Delivery of Hydroxychloroquine Nanostructured Lipid Carrier as a Potential Treatment of COVID-19
Previous Article in Journal
Effect of Preparation Conditions on Application Properties of Environment Friendly Polymer Soil Consolidation Agent
Previous Article in Special Issue
Characteristic and Chondrogenic Differentiation Analysis of Hybrid Hydrogels Comprised of Hyaluronic Acid Methacryloyl (HAMA), Gelatin Methacryloyl (GelMA), and the Acrylate-Functionalized Nano-Silica Crosslinker
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Bone Mineralization in Electrospun-Based Bone Tissue Engineering

Department of Otolaryngology Head & Neck Surgery, University of Alabama at Birmingham, Birmingham, AL 35294-0012, USA
Polymers 2022, 14(10), 2123; https://doi.org/10.3390/polym14102123
Submission received: 29 April 2022 / Revised: 15 May 2022 / Accepted: 20 May 2022 / Published: 23 May 2022

Abstract

:
Increasing the demand for bone substitutes in the management of bone fractures, including osteoporotic fractures, makes bone tissue engineering (BTE) an ideal strategy for solving the constant shortage of bone grafts. Electrospun-based scaffolds have gained popularity in BTE because of their unique features, such as high porosity, a large surface-area-to-volume ratio, and their structural similarity to the native bone extracellular matrix (ECM). To imitate native bone mineralization through which bone minerals are deposited onto the bone matrix, a simple but robust post-treatment using a simulated body fluid (SBF) has been employed, thereby improving the osteogenic potential of these synthetic bone grafts. This study highlights recent electrospinning technologies that are helpful in creating more bone-like scaffolds, and addresses the progress of SBF development. Biomineralized electrospun bone scaffolds are also reviewed, based on the importance of bone mineralization in bone regeneration. This review summarizes the potential of SBF treatments for conferring the biphasic features of native bone ECM architectures onto electrospun-based bone scaffolds.

1. Introduction

Bone grafting has been a standard therapeutic option for bone defects and fractures [1]. Not only do bone fractures result from accidental causes, but osteoporotic fractures are incrementally increasing in aged populations worldwide [2]. Osteoporosis is a skeletal disorder that gradually leads to fragile fractures when a failure-inducing force (e.g., trauma) is applied, and it is a general term describing weakened bone density and bone quality [3]. The imbalance of osteoblastic bone resorption and osteoblastic bone formation results in osteoporosis. Several factors for osteoporosis have been identified, such as genetic, intrinsic, exogenous, and lifestyle factors [4]. Moreover, osteoporosis-related fractures occur in various anatomical positions in the body, such as the spine, hip, and wrist [5]. The annual cost of osteoporotic fractures and osteoporosis was $16 billion per year in the United States [6]. Almost 10 million people older than 50 years old were reported to have osteoporosis, and 1.5 million were estimated to be subject to fragility fractures in the United States [7]. Additionally, osteoporosis has been a leading disease of mortality worldwide, due to increasing life expectancy and longevity [8]. In an ideal case, autologous bone grafting and self-transplantation in the same patient would be considered for treating the bone fractures [9]. However, a limited supply of grafts and patient compliance while harvesting osseous matter has deterred patients from self-transplantation [10]. Alternatively, allopathic bone grafts can be collected from human cadavers [11]. Surgeons have often performed allografts, but the potential risk of contamination, including donor-derived infections, is a deterrence from using these therapeutically viable scaffolds [12,13]. Similar to other tissue-derived products, allografts often hold unexpected pathogenic infections such as bacteria, viruses, and prions [14]. More importantly, allogeneic bones often exert cellular and humoral immune reactions [15]. There are also other donor-based grafts, but they are from nonhuman species. Although such grafts can solve the shortage issue, they need to be prepared through more thorough sterilization protocols, reducing their original potential in osteoinductive properties [16]. Based on a recent study showing the clinical outcomes of bone grafts using allografts, xenografts, and alloplastics in sinus lift or ridge preservation procedures, it has easily been confirmed that an allograft has a better capacity for the creation of new bones than xenografts [17]. As a different approach for bone grafts, demineralized bone matrix (DBM) has been utilized [18,19]. DBM is prepared through a complex process where collected bones are soaked or washed in strong acid reagents (e.g., hydrochloric acid or nitric acid) to eliminate potential contamination and the risk of disease transmission [20,21]. However, the osteoinductivity of DBM is dependent on variations in bone quality from individual donors as well as batch-to-batch process variations [22,23]. In a practical setting, the variation of bone-forming potential in different commercially available DMB products has been documented. It is thought that this is due to the inconsistency of the manufacturing process [24]. The first and foremost benefit of BTE is the provision of well-designed osteoinductive and/or osteoconductive scaffolds for the improvement of bone density and bone quality [25]. Osteoinductive scaffolds are capable of permitting the growth of bone cells. In contrast, osteoconductive scaffolds represent the ability to stimulate primitive and undifferentiated cells (e.g., mesenchymal stem cells [26] and induced pluripotent stem cells [27]) towards bone-forming cells [28]. As a promising scaffolding platform, electrospun-based materials display interconnected porous structures, and become either cellular-based or drug-based scaffolds, thereby increasing the intrinsic potential of bone regeneration, as well as conferring an extrinsically regenerative potential for bone regeneration [29]. For example, a study created a multilayered synthetic fibrous scaffold comprising β-tricalcium phosphate (TCPs) and poly(ε-caprolactone) (PCL) electrospun nanofibers to form bone-like ECMs by the osteoconductive TCPs and the biocompatible elastic PCL nanofibers [30]. Using goat-derived bone marrow stromal cells (BMSCs), the authors proved that electrospun composite scaffolds could increase the osteogenic differentiation of exogenously supplied BMSCs. In this regard, BTE outperforms conventional bone allografts, which are immunogenic and often limited, due to supply shortages [31]. An engineered bone scaffold should have a functional resemblance to a natural ECM, with osteoconductivity for better regenerative outcomes [32]. Electrospun bone scaffolds have highly porous interconnected structures, thereby maximizing their surface area [33]. Moreover, electrospun nanofibers can quickly become a temporary bone substitute by conferring reinforced mechanical strength onto as-spun nanofibers via numerous cross-linking strategies [34]. Hence, the nanofibrous appearance of the as-spun electrospun bone scaffolds dictate the potential for electrospun-based scaffolds in recapitulating the native bone ECM environment, which is one of the critical engineering parameters of BTE [35].
To create functionally augmented electrospun-based scaffolds in BTE, the most common approach is to mineralize electrospun scaffolds to enhance osteogenic potential by mimicking the native bone ECM microenvironment, leading to successful bone grafts and repairs. Incredibly, simulated body fluid (SBF) is a robust but straightforward recipe for inducing hydroxyapatite (HA) and apatite-based inorganic clusters onto the surface of the electrospun scaffolds (Table 1) [36]. These inorganic solutions enable us to create functional electrospun bone scaffolds that are capable of inducing bone regeneration via a dynamic interaction between the synthetic grafts and the endogenously or exogenously provided cells that are responsible for bone regeneration. This study aims to outline numerous electrospinning technologies that are employed in electrospun-based bone scaffolds, and to describe the science of SBF development. Lastly, examples of biomineralized electrospun scaffolds are explored, in order to understand and to expand the potential of biomimetic scaffolds in BTE.

2. Bone: Dynamic and Biphasic Tissue

Bone is a vital tissue that is responsible for essential functions in the body: the mechanical support of the body, locomotion, and dynamic reservoir units for biological components and blood cells (Figure 1) [43]. Bone provides minerals such as calcium, magnesium, and phosphate, and holds bone marrow, particularly red bone marrow, occupied inside the bone tissue to mature and to distribute blood cells. Rather than being a supportive physical frame, bone is a dynamic organ where bone cells and hematopoietic stem cells (HSCs) play a role in maintaining whole-body homeostasis. There are four types of cells in the bone: bone-forming osteoblasts, bone-resorbing osteoclasts, and bone-embedded osteocytes, which are known as a modulator of the cellular activities of osteoblasts and osteoclasts in the dynamic process of bone regeneration [44,45]. The last type of cell, the bone lining cell, has a relatively unclear role or mechanism for coupling bone resorption to bone formation [46]. To fulfill the bone’s role in the body, bone is made of two different types of matter, organic and inorganic components.

2.1. Microstructural Bone Formation: Biphasic Aspects of Bone

The organic part of the bone is typically composed of type I collagen and other structural proteins. Type I collagen (Col1) represents nearly 90% of this part, and contributes to bone strength [48,49]. With a few exceptions, Col1 is a triple-helix of three chains: two α1 chains and one α2 chain [50]. Col1 is enzymatically converted from secreted type I procollagen, like other collagens [51]. With regard to the structural aspect, Col1 is one of the fibrillar collagens that is characterized by a triple-helix conformation and repeated (Gly-X-Y)n sequences [52]. Gly is glycine, while X and Y are different amino acids, meaning that theoretically, more than 400 combinations are possible. However, the Gly-Pro-Hyp triplets are the most prominent combinations present, increasing the molecular stability and the natural intermolecular actions. Collagen molecules can spontaneously form collagen fibrils, which then become collagen fibers and bundles [53]. Such collagen fibrils are also spontaneously created from purified collagen in aqueous solutions [54]. Based on the authors’ observations, collagen liquid crystal can be induced at an acidic pH, since the positively charged residues of collagen help to maintain a liquid state without aggregations, while the rising pH with the aid of ammonia vapors gradually decreases the net charge of the collagen monomers, leading to the formation of collagen fibrils. The brief mechanism of type I collagen fibrillogenesis is mentioned below. Due to the long helical domain of each chain in Col1, the newly-formed three chains spontaneously assemble into triple-helix type I procollagen in the collagen synthesizing cells [55]. In type I procollagen, N-terminal and C-terminal propeptides prevent the formation of the premature collagen fibril, and modulate the fibril assembly [56]. The N- and C-telopeptides are typically 16 and 25 amino acids long, affecting the final self-assembly structures of Col1 [57]. For example, a partial loss of those peptides results in the poor self-assembly of Col1. In contrast, the loss of each telopeptide forms different kinds of self-assembled collagen, indicating that there are other kinetic mechanisms of collagen fibrils. When the type I procollagen is secreted into the extracellular space, abundant proteolytic enzymes such as matrix metalloproteinases (MMPs) and bone morphogenetic protein 1 (BMP-1) are responsible for initiating spontaneous collagen fibril formation [58]. Such enzymes target the N-terminal and C-terminal propeptides from the type I procollagen. For example, a disintegrin and a metalloprotease with thrombospondin type I motifs (ADAMTS), ADAMTS-2, can cleave the N-terminal propetides [59]. Likewise, ADAMTS-14 is also observed to have similar aminoprocollagen peptidase activity [60]. Bone morphogenetic protein-1 (BMP-1) can also excise the C-terminal propetides [61].
The inorganic bone minerals represent approximately 60% of bone tissue by weight and 40% by volume [62]. The bone minerals have two distinct roles: (1) they act as a reservoir of ions for the body, and (2) they are embedded in the organic components of the bone to create a light and tough natural composite material [63]. Bone minerals are important in ion homeostasis, regulating approximately 99% of the calcium and 85% of the phosphorus in the body [64,65].
Similarly, sodium and magnesium in the bone account for at least half of the required levels in the body (nearly 90% and 50%, respectively) [66]. In nature, both components become a biological composite with multi-level hierarchical properties [67]. Mineralized collagen can be considered to be a building block that creates the hierarchical structure of bone. The mineralized collagen by itself is thought to be a reinforced collagen composite where thin calcium phosphate-based crystals are intercalated between collagen nanofibrils [68]. Mineralized collagen fibrils eventually become a unit of lamellar bone structures. In this biphasic bone structure, the collagen-based organic ECM regulates the cellular activities of the bone-resident and the bone-forming cells. At the same time, the HA-based ECM plays a role in the structural support of bone [69]. As a result, a bundle of fibrillar collagens can be observed. Interestingly, each fibrillar collagen can undergo a further enzymatic cross-linking process, leading to a lysine-mediated intermolecularly cross-linked collagen bundle [70]. From the viewpoint of the structural locations of the cross-linking, this occurs between the short non-helical peptides (N- and C-terminal telopeptides) and a helical portion of an adjacent collagen molecule [71]. It is known that all major collagens, types I, II, and III, have four cross-linking sites at equivalent locations of each collagen molecule. Moreover, Col1 has unique cross-linking products, called pyridinoline cross-links, which interconnect between the N-telopeptide and the helix intermolecular cross-linking domain of the Col1 molecules [72]. Hence, biomineralization and extra cross-linking properties contribute to the complex hierarchy of the bone.

2.2. Macrostructural Bone Formation: Vascularization and Ossifications

In a macroscopic aspect, bone is a highly vascularized connective tissue, where bone vasculature participates in bone development (endochondral and intramembranous ossification), bone remodeling, and the regeneration of bone [73]. The trabecular bone is spongy bone tissue that is observed at the ends of a long bone, while compact bone, also called cortical bone, is the dense exterior bone [74]. The intricate vascular network pervading the Haversian and Volkmann’s canals is observed in the cortical bone. The Haversian canals are the longitudinal route of blood vessels in the cortical bone, while the Volkmann canals interconnect the blood vessels of the Haversian canals [73]. Haversian systems or osteons are the basic units of compact bone. Each osteon is composed of lamellae of compact bone tissue derived from mineralized collagen fibrils and osteocytes that are founded in small cavities of each osteon, called lacunae [75]. Thin tubes called canaliculi from each lacuna serve not only as paths for blood supply, but also for the spaces that allow osteocytes to connect to each other through gap junctions [76]. Notably, the center of each osteon is called the Haversian canal, which contains blood vessels and nerve fibers that are parallel to the long axis of the bone. Bone can form via intramembranous ossification (osteogenesis) and endochondral ossification [77]. Endochondral ossification is the process of bone formation, during which chondroblasts (mesenchymal progenitor cells for cartilage formation) form a membrane called the perichondrium around a cartilage template. These chondroblasts become chondrocytes that secrete growth factors for recruiting blood vessels towards the perichondrium. Then, the perichondrium becomes the bone-forming periosteum. In contrast, intramembranous ossification is the immediate bone-forming process without the involvement of a cartilage model, which is shown in endochondral ossification. Endochondral ossification can be found in the long bones, whereas most skull bones are formed through intramembranous ossification [78,79].

2.3. Bone Remodeling and Bone Healing

Bone remodeling is the two-step process by which osteoclasts break old bone tissues down, followed by bone deposition, which replaces new bone tissues through the cellular activities of bone-forming osteoblasts [79]. As a dynamic tissue of the body, the bones are constantly under bone remodeling for the following reasons: (1) remodeled bones support newly applied mechanical stresses upon the bone architecture; (2) bone remodeling maintains ion homeostasis by regulating calcium and phosphate ions in the body; (3) bone remodeling repairs microdamage to the bone [80].
In fracture healing, there are several types of fractures after post-reduction treatment; the broken bones undergo the healing process. Damaged blood vessels that are associated with the fractures create a hematoma (localized bleeding) and induce clot formation around the damaged bone [81]. The clots help to recruit new blood vessels and become fibrous granulation tissues called soft calluses. Approximately 1 week after injury, the soft callus turns into a fibrocartilaginous callus, which eventually becomes a bony callus approximately 2 months later. Further bone remodeling and reshaping occur over several months to complete the stages of the fracture repairs [82].

3. Electrospinning Technologies: Electrospun Scaffolds in Bone Mineralization

Although there are many technical approaches for creating nano-sized ECM-like threads or fibers such as self-assembly, phase separation, and electrospinning, the versatile electrospinning strategy outweighs other methods in terms of material selection, post-modifications, and adaptability to other scaffold platforms (Figure 2) [83,84,85]. Different versions of the original electrospinning strategy enable us to confer more delicate morphological features onto the final electrospun nanofibers for regenerative bone scaffolds (Table 2). For example, a coaxial electrospinning technique creates dual growth-factor-loaded electrospun scaffolds to enhance osteoconduction and osteoinduction [86]. Likewise, triaxial electrospun scaffolds have the potential for developing multifunctional nanofibers. A recent study showed that a tripolymeric triaxial electrospun scaffold supports the cellular activity of rat adipose-derived stem cells (ADSCs) [87]. In the melt electrospinning technique, distinctive non-woven nanofibrous architectures can be fabricated by maintaining a polymeric solution in a highly viscous liquid while performing the electrospinning [88].

3.1. Monoaxicial Electrospinning

William Gilbert initiated the basic concept of electrospinning in 1600. Under an electric field, he discovered the cone-shaped water droplet, which was eventually named the ‘Taylor cone’, since Geoffrey Taylor documented the mathematical modeling of the conical shape of a polymer solution when applying a strong electric field, in his seminal works in the 1960s [100]. Using a simple instrument, a sufficient electric potential can be imposed upon a polymer solution to create the Taylor cone. The basic setup of an electrospinning machine has four components: (1) a high-voltage power supply, (2) a syringe pump, (3) a spinneret, and (4) a conductive collector. Before electrification, a driving force that is applied to a polymer solution in a syringe creates a pendant-shaped droplet in the tip of a spinneret, where surface tension governs and results in the spherical shape of the solution. However, when an electric potential is accumulated in the solution, the electrostatic force sufficiently surpasses the surface tension to create a Taylor cone, continuously drawing polymeric fibers onto a conductive collector. During the charged polymeric liquid’s travel, it converts into a series of solid nano-sized threads due to solvent evaporation. Electrospun scaffolds fabricated by a traditional electrospinning technique hold several favorable features for BTE. They have a large surface area-to-volume ratio, a high porosity, and a similar morphological shape to native bone ECM [101]. Before using the electrospun scaffold in BTE, biocompatible polymeric foams were investigated, giving an insight into the preferred material design parameters for BTE. Using poly(α-hydroxy acid) foam scaffolds, a previous study demonstrated that a preferable bone scaffold would have an interconnected internal structure with at least 90% porosity and a 100 to 350 µm pore size [102]. It is not convenient to fabricate such highly porous micro-channeled structures using the phase separation technique, but the electrospinning technique can easily make bone remodeling scaffolds with minimum effort. A simple but meaningful study showing the potential of the electrospinning technique in BTE has been reported [103]. In this study, the authors created a microporous and non-woven PCL scaffold by a monoaxial electrospinning technique, demonstrating the attachment and growth of mesenchymal stem cells (MSCs) derived from the bone marrow of neonatal rats. Because of this simple and efficient manufacturing method, monoaxial electrospinning remains a standard technique for creating a regenerative bone scaffold. A growth factor, basic fibroblast growth factor (bFGF), for supporting BMSCs was successfully incorporated into a monoaxial electrospun scaffold. It showed a sustained release of bFGF over time [104]. Rabbit BMSC seeded onto monaxial poly(lactic-co-glycolic acid) (PLGA) was expanded and stimulated by slowly released bFGF to produce type I collagen, as well as fibronectin, over 1 week. In general, monoaxial electrospinning is an essential and effective tool for creating functional electrospun scaffolds for BTE.

3.2. Melt Electrospinning

The melt electrospinning technique can create a straight and stable polymer jet. Instead of using a solvent-based polymer solution for electrospinning, a heating element around a syringe allows us to make a molten polymer with relatively high viscosity and low conductivity. An ejected stable jet of molten polymer from an electrospinning apparatus, in general, creates thicker nanofibers but well-designed electrospun architectures over two or three dimensions. Due to its lack of requirement for solvents, melting electrospinning is also considered to be a green nanotechnology. Because solvent residuals in a biomaterial-based product affect the biocompatibility of the product, electrospun scaffolds obtained using this novel technique would be a promising approach for creating more sophisticated but also safer electrospun-based bone scaffolds [105]. A study utilized melt electrospinning to create a hybrid scaffold using conventional electrospinning and melt electrospinning [106]. Using silk fibroin (SF) and PCL, the authors successfully fabricated SF/PCL nano/microfibrous composite scaffolds and proved that the composites were supportive of the osteogenic potential of human mesenchymal stem cells (hMSCs) isolated from the alveolar bones of patients during oral surgery. Similar to the advancement of different electrospinning technologies, melt electrospinning has also evolved into melt electrowriting (MEW), a combined technology of electrospinning and fused deposition modeling (FDM) that is the most well-known extrusion-based additive manufacturing method [107]. One of the fabrication benefits of MEW is that it can create a highly porous structure with adjustable filament size (5 to 50 µm) [108]. A study created a flexible and osteoconductive fibrous composite made of PCL and HA based on the MEW process [109]. This study incorporated HA nanoparticles into a PCL solution to create a composite solution followed by the melt electrospinning writing process. The fabricated HA/PCL composite had a high degree of porosity (96−98%) and fully interconnected pore architectures, thereby supporting the osteoactivity of human osteoblast cells.

3.3. Aligned/Oriented Electrospinning

Recent progress in BTE has also encouraged electrospinning technology to fabricate more aligned and ordered nanofibers that assist with the design of osteoinductive and osteoconductive electrospun scaffolds. Compared to non-aligned nanofibers, aligned nanofibers modulate cell adhesion and migration, and they affect the production of ECM and cytokines [110]. NIH-3T3 fibroblast cells were attached and spread along with the aligned nanofibers by modifying the cellular cytoskeleton onto the aligned electrospun nanofibers. The topological characteristics of a substrate can influence cellular behaviors, including growth and differentiation [111]. In BTE, recent studies using aligned electrospun nanofibers have demonstrated the role of fiber orientation to the extent to which several stem cells undergo osteogenic differentiation. In a study, random and parallel poly (l-lactic acid) (PLLA) nanofibers were fabricated to evaluate the effects of fiber orientation on cell morphology, proliferation, and the differentiation of osteoblast-like MG63 cells [112]. MG63 cells grew along the aligned direction of the PLLA electrospun nanofibers. However, no statistically conclusive data showed better osteogenic potential in the aligned nanofibers. In contrast with the above study, using an osteoblast-like cell line, a study used human bone marrow mesenchymal stem cells (hBMSCs). It demonstrated the positive effects of both the aligned PLLA electrospun nanofibers and the aligned microfibers on the osteogenic differentiation of the stem cells [95]. The aligned nanofibers (AN) had average fiber diameters of 580 ± 10 nm, whereas the aligned microfibers (AM) in this study were demonstrated on a micro-size scale (1.21 ± 0.15 μm). Both the aligned or random electrospun nanofibers enhanced the osteogenic potential of the hBMSCs. Compared to the random electrospun fibers (random nanofiber; RN and random microfiber; RM), both the aligned fibers caused the hBMSCs to extend along the elongated direction of the fibers. In addition, hBMSCs on the aligned fibers showed faster migration speeds than the random fibers. Lastly, such morphological behaviors of hBMSCs on the aligned fibers reflect improvements in osteogenic differentiation, which were assessed via alkaline phosphatase (ALP) staining and alizarin red (ARS) staining. ALP is one of the most reliable markers produced from osteogenic cells, while ARS staining is a common assay technique for the cellular mineralization of various osteogenic cells [113,114]. Based on the hBMSCs’ cellular behaviors as measured on days 7 and 10, the AN group showed stronger ALP staining intensity than did other groups (AM, RN, and RM). Similarly, ARS staining performed 21 days after seeding the stem cells on each substrate indicated that the AN group exhibited a significantly higher staining intensity than the other groups. These findings likely confirm that the aligned nanofibers are better osteoinductive bone scaffolds than the normal electrospun scaffolds that are usually fabricated using a conventional electrospinning apparatus. To create aligned nanofibers, numerous invented approaches have been addressed. A straightforward means of collecting aligned fibers is to use a rotating collector. Instead of using a static and flat collector, a study adopted a mandrel collector rotating at high speeds (e.g., 4500 rpm) while collecting nanofibers that were continuously ejected from a Taylor cone [115]. Further improvements in fabricating aligned nanofibers were also made by applying auxiliary counter electrodes onto the surface of a mandrel. The auxiliary electrodes created a converged electric field, thereby forming an aligned and dense electrospun scaffold without any apparent change in the average diameters of the aligned nanofibers [116]. As a different technique for alignment, a study used two separated parallel conductive collectors onto which the charged nanofibers were stretched and covered between the gap between the collectors [117]. The concept of the conductive parallel collector was also adopted in a mandrel [118]. In this technique, evenly spaced copper wires aligned through the barrel of a mandrel were placed to create a circular drum that served as a collector of the electrospun nanofibers. Because of the combinational effect of the mechanical stretching force by a mandrel and the electrostatic interactions between a parallel collector, aligned nanofiber sheets can be collected easily without disturbing the aligned structure. A different study introduced a new rotor-type collector with perpendicularly standing fins to assist wind-electrospun filaments in large amounts during electrospinning [119]. Whereas the above technologies have been focused on improving or modifying some of the four components in an electrospinning machine, magnetic electrospinning (MES) uses a polymer blend containing a small amount of magnetic materials to magnetize the ejected polymer, thereby creating aligned nanofibers under a magnetic field [120]. Additional forces, such as the post-drawing force and the centrifugal force, are also utilized to create aligned nanofibers. A study using PLLA nanofibers already aligned by approximately 60% confirmed that applying a post-drawing force in an oven at a high temperature (110 °C) using a manual drawing device results in the improved alignment of the electrospun PLLA nanofibers by up to 90% [119]. Using an additional centrifugal force in electrospinning, large-scale aligned nanofibers can be obtained as an electrospun mat with a rapid fabrication time [121]. Notably, the aligned electrospun nanofibers affect the morphological features of the attached cells. The aligned poly(d,l-lactic acid) (PLA) nanofibers changed the cellular morphology of the bone marrow stromal cells and showed an increased degree of calcium deposition during osteogenic differentiation [122]. An inverse relationship between alignment and osteogenic potential has recently been documented [123]. Human embryonic stem cell-derived mesenchymal progenitor cells (hES-MPs) on random gelatin-coated PCL electrospun nanofibers showed better rates of mineralization and osteogenic differentiation, as confirmed by both the ALP and ARS activities. Inversely, the mature osteoblast cell line MLO-A5 showed enhanced ALP activity and more calcium deposition in the same but aligned scaffold. The dependency of both the cell-specific and the nanofiber alignments on developing electrospun bone scaffolds should be considered as a design parameter for the pursuit of an ideal electrospun-based scaffold for BTE.

3.4. Multi-Axial Electrospinning

Compared to monoaxial electrospinning, multi-axial electrospinning requires a special spinneret and greater consideration when choosing appropriate experimental parameters to succeed in fabricating multi-layered electrospun nanofibers. However, the fabricated multi-layered electrospun nanofibers would expand the potential for electrospun scaffolds in multiple biomedical applications, including BTE. The most frequently studied multi-axial electrospinning technique is coaxial electrospinning, which is similar to monoaxial electrospinning, except for a special spinneret and an associated modification (two pump-driven reservoirs). In terms of a spinneret in the coaxial electrospinning technique, a coaxial spinneret is an outer-shell spinneret that is concentrically aligned. For co-axial electrospinning, several experimental considerations have been addressed: (1) a sheath solution is usually being with higher viscosity and better conductivity compared to a core solution; (2) the flow rate of a sheath solution has to be faster than that of a core solution; (3) there is low interfacial tension present between the core and sheath solutions used; and (4) relatively volatile solvents are recommended for a sheath solution to create a stable Taylor cone formation [124]. In addition, the selection of solvents for multiple-axial electrospinning is also a cumbersome parameter for generating successful core/sheath nanofibers [125]. According to the author’s comments, each solvent system for both the core and sheath polymeric solutions affects the final structure of the core/sheath nanofibers. When the core and sheath solvents are miscible, each polymer used should not be soluble in another solvent system. Otherwise, the solutes could precipitate, even within the tip of the spinneret used. In contrast, immiscible solvent systems create stable core/sheath nanofibers, even if each polymer can diffuse into another solvent system, while miscible solvent systems are suitable for creating nanofibers through coaxial electrospinning. In addition to the advantage of monoaxial electrospun nanofibers, the coaxial nanofibers bring more versatile features to the final tissue-engineered products [126]. The features can be summarized as follows: (1) the sheath portion can serve as a biophysical protective barrier for deposited drugs within the core portion; (2) the release of the drugs can be modulated by controlling the thickness of each portion while electrospinning; and (3) the mechanical properties of the coaxial nanofibers are adjustable to meet the mechanical requirement of the native bone tissues. Due to the morphological benefits of the coaxially electrospun scaffolds, for example, numerous studies in BTE have been found elsewhere. Using a rotating needle collector, a study fabricated a coaxial PCL/HA-added PLA electrospun tube that was capable of growing human mesenchymal stem cells [127]. Additionally, BMP-2 growth factors were slowly released from the fabricated tubes, irrespective of the presence of HA. A study used tussah silk fibroin to incorporate HA into the sheath of coaxial electrospun scaffolds [128]. This coaxial electrospun scaffold also used tussah silk fibroin for the core. The core/sheath nanofiber can also be used to deliver a drug that has been deposited within the core of the core/sheath nanofibers. A study incorporated TCP nanoparticles into the core of the core/sheath electrospun scaffolds and compared the release profile of the TCP nanoparticles from the coaxial PLA nanofibers with morphologically different PLA nanofibers, including monoaxial nanofibers [129]. When the TCP nanoparticles were added, the average size of the electrospun nanofibers was significantly changed. The monoaxial nanofibers had average fiber diameters of 450 ± 72 nm, whereas the coaxial nanofibers had approximately double diameters (890 ± 125 nm). Owing to the successful embedding of the TCP nanoparticles into the core part, the coaxial nanofibers had a smooth surface, indicating that no TCP nanoparticles were found on the surface of the nanofibers. As expected, the release of the TCP nanoparticles from the coaxial electrospun were markedly delayed and extended for 36 days. While the monoaxial electrospun released most TCP nanoparticles within several days, the coaxial electrospun maintained constant release profiles. Multi-axial electrospinning would be an excellent platform that delivers agents (e.g., BMP-2 or -7 growth factors) for promoting bone regeneration. In addition to serving as a biomimetic bone-like ECM, the core-sheath nanofibers can provide therapeutic agents in the desired manner. Moreover, the structural advantage of the core-sheath nanofibers is that these distinctive layers could retain the therapeutic activity of the incorporated agents Hence, the multi-axial electrospinning strategy makes electrospun scaffolds capable of satisfying the unmet needs of various bone defects.

4. Simulated Body Fluid for Bone Scaffold Mineralization

Mineralized collagen fibrils are responsible for the elastic modulus of bone and bone fracture toughness. In addition to the density of apatite, the deposited HA size, orientation, and localization are parameters that affect the strength of bone [130]. An SBF is a solution preparation that creates the bone-like apatite layer upon various substrates, including polymers, ceramics, and metals [131]. Inspired by human blood plasma, several SBFs have been formulated by modifying different ion compositions (Table 3). By convention, a conventional SBF is called c-SBF. Its compositional formulation is similar to human blood plasma, with the exception of two ions, chloride anion (Cl) and bicarbonate anion ( HCO 3 ) [132]. The concentration of Cl in c-SBF was higher than that of blood plasma, whereas c-SBF has significantly lower HCO 3 levels than in blood plasma. An interesting study recently showed that regular cell culture media might be an alternative to normal SBF [133]. Since the inception of an SBF formation, a series of studies has been performed to improve the efficacy of SBF formulations. Compared to the conventional SBF (c-SBF) formulation, for example, three improved formulations have been studied: (1) Revised SBF (r-SBF) represents a reduction in Cl and an increase in HCO3 concentration compared to those of c-SBF; (2) ionized SBF (i-SBF) has the lowered concentrations of two divalent cations (Ca2+ and Mg2+) compared to those of r-SBF; and (3) modified SBF (m-SBF) has a moderate HCO3 level compared to the levels of both r-SBF and i-SBF [134]. By comparing three formations, m-SBF was selected as a suggested SBF formulation, since m-SBF makes bone-like apatite onto substrates and demonstrates a similar degree of storage stability to c-SBF when stored at 36.5 °C for 7 days. Revised SBF (r-SBF) and modified SBF (m-SBF) were much closer to the compositions of human blood plasma, but those formulations were lacking in creating bone-like apatite for calcium-based materials. A revised SBF formulation called n-SBF, which stands for a newly improved SBF, was also studied [135]. For example, a study created a microporous composite scaffold in which natural gellan gum (GG) and nanoparticulate bioactive glass (BAG) were blended in a solution containing calcium chloride (CaC12) and mineralized with flow SBF [136]. In this study, a perfused SBF flows in the axial direction with or without the presence of vertical direct compression to create the best biomimetic scaffold containing HA for BTE. The authors observed that the perfused SBF flow forms cauliflower-like HA within the GG–BAG scaffolds that are comparable to HA crystals observed in vivo. However, the application of direct compression reduces the formation of HA, followed by the destruction of the GG–BAG scaffolds.

5. Simulated Body Fluids for Electrospun-Based Bone Scaffolds

Mineralized electrospun scaffolds have been fabricated by the simple immersion of electrospun nanofibers in different SBFs, ranging from regular SBFs to concentrated SBFs (Table 4). In this section, various mineralized electrospun scaffolds have been addressed to confirm the potential of this excellent but straightforward strategy for electrospun biomineralization. PCL electrospun nanofibers were pretreated with NaOH (2N, 24 °C for 12 h) and mineralized in SBF for up to 21 days [137]. From the analysis of the selected area using electron diffraction (SAED) pattern and energy dispersive spectroscopy (EDS) measurements, it was confirmed that the mineralized PCL nanofibers exhibited a similar ring-shaped pattern to that of crystalline apatite. The ratio of Ca/P was approximately 1.71, which was comparable to the value of HA (Ca/P~1.67). When used to cultivate MC3T3-E1 subclone 4 cells, which are known to be a good model of in vitro osteoblast differentiation via ECM signaling, the HA-mineralized PCL nanofibers showed better osteogenic performance potential than in the case of the non-treated nanofibers [138]. In another study using PCL electrospun scaffolds, vitamin D3 (VD3) containing anionic SDS micelles (SDS; sodium dodecyl sulfate) were intercalated between layered double hydroxides (LDHs), which are known to be the most biocompatible inorganic nanocarriers in the drug delivery system [139]. Then, the fabricated VD3·LDH/PCL electrospun scaffolds were mineralized within concentrated SBF (10×) (Figure 3). Interestingly, an increase of the VD3·LDH nanohybrids within the PCL-based electrospun scaffolds enhanced apatite-like crystal formation in vitro. Based on recent findings regarding vitamin D3 (VD3) in inducing osteoblastic differentiation, this study incorporated VD3 and evaluated the osteogenic potential of the VD3 loading electrospun bone scaffolds with human osteoblast-like MG-63 cells.
For improving the mineralization of PLLA electrospun nanofibers, a concentrated SBF (×10) was utilized after treatment with either NaOH (0.1 M) or co-blending with gelatin (10%) [140]. Such pretreatments assist with the mineralization of the electrospun nanofibers within 2 h, in the concentrated SBF. However, co-blending with gelatin was better at yielding the stress and elastic modulus than the NaOH-treated PLLA nanofibers, indicating the gelatin-derived hydrophilic properties of the 10% gelatin/PLLA nanofibers could facilitate mineralization. In another study, amorphous calcium particles (ACPs) were added to enhance the mineralization process onto the PLA electrospun nanofibers, which are similar to another PLLA hydrophobic synthetic polymer [141]. Only a 1-day treatment in an SBF solution showed significant growth of inorganic HAs on the surface of ACP containing PLA nanofibers. In contrast, no change was observed on the surface of the pure PLA nanofibers, even after immersion in SBF for 7 days.
Table 4. Exemplary uses of simulated body fluid (SBFs) in electrospun-based bone scaffolds.
Table 4. Exemplary uses of simulated body fluid (SBFs) in electrospun-based bone scaffolds.
Type of Electrospun ScaffoldTreated SBF ProtocolDescriptionsRef.
PLGA/collagen/gelatin
(2:1:1 weight ratio)
10× m-SBFThe mineralized PCG nanofibers were fragmented and loaded with BMP-2 mimicry peptides 1 for alveolar bone regeneration in vivo.[142]
Liginin/PCL1.5× SBFThe fibrous liginin/PCL films were completely coated by HA within 5 days.[143]
Alginate/PLA1.5× SBFThe alginate/PLA composite was crosslinked by Ca2+ and mineralized. Anionic alginate assists with the nucleation and growth of calcium phosphate apatites.[144]
Polysilsesquioxane (POSS)-loaded PLA1× SBFThe POSS-PLA showed acceleration in HA mineralization.[145]
1 Bone morphogenetic protein-2 (BMP-2) is a well-known growth factor capable of inducing osteogenesis. The BMP-2 mimicry peptides are derived from BMP-2, and they have a poly-glutamic acid residue (E7 Tag) for electrostatic interaction between the peptides and HAs.
Likewise, carbonate nano-hydroxyapatite (n-HA) was incorporated into an electrospinning solution to induce mineralization [146]. Although electrospun nanofibers fabricated from a copolymer of L-lactide and DL-lactide (PLDL) were not mineralized properly for a 7-day immersion within a 1.5-fold SBF solution, n-HA/PLDL nanofibers have successfully undergone the process of full HA mineralization after 3 days of immersion. Similarly, PCL nanofibers containing HA nanoparticles (NPs) were mineralized within an SBF solution for 10 days at 37 °C [147]. It was confirmed that the embedding of HA-NPs initiates the crystallization of HA from the SBF treatment, and that an incremental addition of HA-NPs in PCL colloidal solutions improved the formation of bone-like apatite.
For better mineralization, a study used gelatin and amino acids (e.g., glycine, aspartic acid, and arginine) [148]. A polymeric blend of PLLA and gelatin (1:1 weight ratio) was used for electrospinning, while each amino acid (2.5 mM) was supplemented into a concentrated SBF (2.5×). At different incubation periods, the authors observed significant differences in mineralization. Compared to concentrated SBF (2.5×), the presence of amino acid facilitates HA crystal formation, transforming it from amorphous calcium phosphate to hierarchical HA (Figure 4). Among the amino acids, the authors also noted that glycine had promoted the formation of well-evolved needle-like HA crystals. It was speculated that adding amino acids into SBF would assist with inducing biomineralization for electrospun-based bone scaffolds.
Interestingly, a study used a charged protein that could enhance the process of mineralization while applying a concentrated SBF (10×) [149]. In this study, phosvitin (PV), one of the egg (usually hen eggs) yolk phosphoproteins, was utilized to obtain a better rate of mineralization on the surface of the collagen nanofibers [150]. The involvement of PV in the concentrated SBF (×10) resulted in the rapid formation of apatite within 4 h, which was comparable to HA, and confirmed by EDS analysis. Instead of incorporating an additive or a treatment with NaOH for modifying the surface of the pure electrospun nanofibers, a study employed a collagen coating technique onto the prepared PLGA nanofibrous mesh (NFM) [151]. After collagen coating, a concentrated SBF (5×) treatment resulted in the formation of tiny HA nanoparticles onto NFM. The HA-coated NFM supported the growth of the MC3T3-E1 osteoblasts and their subsequent differentiation. Additionally, the osteogenic differentiation of the BMSCs proved the potential of the HA-deposited collagen-coated PLGA electrospun mesh in BTE. Onto the blend of electrospun nanofibers from hydroxyethylcellulose (HEC) and polyvinyl alcohol (PVA), concentrated SBF (10×) was also utilized to coat them with bone-like apatite within 2 days [152].
The mineralization technique is also a promising strategy for electro-conductive biomaterials that are capable of transferring electric stimulations onto cells. The electrical stimulation would help to promote bone regeneration. Under periodic electrical stimulation (1 h per day, 0.4 ms pulse, and 20 Hz frequency) with different voltages (1, 5, 10, and 15 V), human fetal osteoblastic cells (hFOB 1.19) cultured on the surface of anodized nanotubular titanium were responsive [153]. Significantly, an electric field generated at 15 V enhanced osteoblast growth up to 72% after 5 days. In addition, osteoblasts move toward the cathode, and osteoclasts move in the opposite direction (the anode) [154]. As mentioned in this study, this cell galvanotaxis is a unique property that may contribute to the development of new BTE for difficult-to-access bone fractures. Electro-conductive electrospun carbon nanofibers (CNFs) would be an excellent substrate for electrical stimulation in BTE applications [155]. Using an SBF formulation, a study successfully synthesized HA-mineralized electrospun CNFs derived from polyacrylonitrile (PAN) [156]. This study confirmed that a typical SBF post-treatment created hydrophilic and biomimetic CNFs while preserving the conductive properties of carbon. Even after 24 h, SBF post-treatment resulted in the uniform mineralization of CNFs when pristine CNFs (P-CNF) were pretreated with a concentrated NaOH solution (5 M) at 45 °C. The pre-treated CNFs (T-CNFs) were thought to form mineral phase nucleation sites on the surface of the T-CNFs due to the exposure of the surface carbonyl groups. In a rat bone defect model where 6 mm segmental damage was created in the femurs of Wistar rats, the mineralized CNFs (M-CNF) completely restored the bone defects of the femurs within 8 weeks (Figure 5). In summary, the SBF treatment is a standardized protocol for conferring biomineralization onto electrospun nanofibers. Interestingly, there have been attempts to boost the biomineralization process via the following approaches: (1) pretreating as-spun scaffolds to create a more wettable charged surface; (2) adding functional agents that induce or expedite SBF nucleation; (3) coating the surfaces of electrospun scaffolds to enhance the initiation of the mineralization process.

6. Conclusions

Improvements in the development of synthetic bone grafts have aspired to fill the gap between the constant need for bone substitutes and the shortage of bone tissues for bone defects and bone fractures, including osteoporotic fractures. Electrospinning has been extensively explored as a promising manufacturing strategy for creating a biomimetic bone scaffold. Electrospun scaffolds have high porosity, a large surface-area-to-volume ratio, and structural similarities to native bone ECM. For bone-like scaffolds, the imitation of the biphasic nature of native bone ECM is critical because mineralization makes the bone harder and more capable of mechanically supporting the body, implementing the ability to move, and supplying a dynamic reservoir of biologically essential elements (e.g., minerals, blood cells, and growth factors). Therefore, an in-situ mineralization technique with different simulated body fluids (SBFs) has been extensively adopted to create fully biomimetic electrospun-based bone scaffolds. This reliable and straightforward post-treatment has successfully fabricated various mineralized electrospun bone-like scaffolds. As reviewed in this study, recent research progress in SBF-based mineralization protocols has made mineralized electrospun scaffolds much more versatile in repairing bone defects and fractures.

Funding

This study was supported by the Convergence of Conventional Medicine and the Traditional Korean Medicine R&D program funded by the Ministry of Health & Welfare through the Korea Health Industry Development Institute (KHIDI). (HI16C0322).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Greenwald, A.S.; Boden, S.D.; Goldberg, V.M.; Khan, Y.; Laurencin, C.T.; Rosier, R.N. Bone-Graft Substitutes: Facts, Fictions, and Applications. JBJS 2001, 83, S98–S103. [Google Scholar] [CrossRef] [PubMed]
  2. Rosen, C.J. A Not-So-New Treatment for Old Bones. N. Engl. J. Med. 2018, 379, 2465–2466. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 2001, 285, 785–795. [Google Scholar] [CrossRef] [PubMed]
  4. Föger-Samwald, U.; Dovjak, P.; Azizi-Semrad, U.; Kerschan-Schindl, K.; Pietschmann, P. Osteoporosis: Pathophysiology and therapeutic options. EXCLI J. 2020, 19, 1017–1037. [Google Scholar] [CrossRef]
  5. Tu, K.N.; Lie, J.D.; Wan, C.K.V.; Cameron, M.; Austel, A.G.; Nguyen, J.K.; Van, K.; Hyun, D. Osteoporosis: A Review of Treatment Options. P T 2018, 43, 92–104. [Google Scholar]
  6. Blume, S.W.; Curtis, J.R. Medical costs of osteoporosis in the elderly Medicare population. Osteoporos. Int. 2011, 22, 1835–1844. [Google Scholar] [CrossRef] [Green Version]
  7. Clynes, M.A.; Harvey, N.C.; Curtis, E.M.; Fuggle, N.R.; Dennison, E.M.; Cooper, C. The epidemiology of osteoporosis. Br. Med. Bull. 2020, 133, 105–117. [Google Scholar] [CrossRef]
  8. Salari, N.; Ghasemi, H.; Mohammadi, L.; Behzadi, M.h.; Rabieenia, E.; Shohaimi, S.; Mohammadi, M. The global prevalence of osteoporosis in the world: A comprehensive systematic review and meta-analysis. J. Orthop. Surg. Res. 2021, 16, 609. [Google Scholar] [CrossRef]
  9. Robinson, P.G.; Abrams, G.D.; Sherman, S.L.; Safran, M.R.; Murray, I.R. Autologous Bone Grafting. Oper. Tech. Sports Med. 2020, 28, 150780. [Google Scholar] [CrossRef]
  10. Betz, R.R. Limitations of autograft and allograft: New synthetic solutions. Orthopedics 2002, 25, s561–s570. [Google Scholar] [CrossRef]
  11. Roberts, T.T.; Rosenbaum, A.J. Bone grafts, bone substitutes and orthobiologics: The bridge between basic science and clinical advancements in fracture healing. Organogenesis 2012, 8, 114–124. [Google Scholar] [CrossRef] [Green Version]
  12. Fishman, J.A.; Greenwald, M.A.; Grossi, P.A. Transmission of Infection With Human Allografts: Essential Considerations in Donor Screening. Clin. Infect. Dis. 2012, 55, 720–727. [Google Scholar] [CrossRef] [Green Version]
  13. Deijkers, R.L.; Bloem, R.M.; Petit, P.L.; Brand, R.; Vehmeyer, S.B.; Veen, M.R. Contamination of bone allografts: Analysis of incidence and predisposing factors. J. Bone Jt. Surgery. Br. Vol. 1997, 79, 161–166. [Google Scholar] [CrossRef]
  14. Ng, V.Y. Risk of disease transmission with bone allograft. Orthopedics 2012, 35, 679–681. [Google Scholar] [CrossRef] [Green Version]
  15. Shegarfi, H.; Reikeras, O. Review article: Bone transplantation and immune response. J. Orthop. Surg. 2009, 17, 206–211. [Google Scholar] [CrossRef]
  16. Shibuya, N.; Jupiter, D.C. Bone graft substitute: Allograft and xenograft. Clin. Podiatr. Med. Surg. 2015, 32, 21–34. [Google Scholar] [CrossRef]
  17. Nappe, C.E.; Rezuc, A.B.; Montecinos, A.; Donoso, F.A.; Vergara, A.J.; Martinez, B. Histological comparison of an allograft, a xenograft and alloplastic graft as bone substitute materials. J. Osseointegr. 2016, 8, 20–26. [Google Scholar]
  18. Gruskin, E.; Doll, B.A.; Futrell, F.W.; Schmitz, J.P.; Hollinger, J.O. Demineralized bone matrix in bone repair: History and use. Adv. Drug Deliv. Rev. 2012, 64, 1063–1077. [Google Scholar] [CrossRef]
  19. Kadam, A.; Millhouse, P.W.; Kepler, C.K.; Radcliff, K.E.; Fehlings, M.G.; Janssen, M.E.; Sasso, R.C.; Benedict, J.J.; Vaccaro, A.R. Bone substitutes and expanders in Spine Surgery: A review of their fusion efficacies. Int. J. Spine Surg. 2016, 10, 33. [Google Scholar] [CrossRef] [Green Version]
  20. Pang, S.; Su, F.Y.; Green, A.; Salim, J.; McKittrick, J.; Jasiuk, I. Comparison of different protocols for demineralization of cortical bone. Sci. Rep. 2021, 11, 7012. [Google Scholar] [CrossRef]
  21. Figueiredo, M.; Cunha, S.; Martins, G.; Freitas, J.; Judas, F.; Figueiredo, H. Influence of hydrochloric acid concentration on the demineralization of cortical bone. Chem. Eng. Res. Des. 2011, 89, 116–124. [Google Scholar] [CrossRef]
  22. Russell, J.L.; Block, J.E. Clinical utility of demineralized bone matrix for osseous defects, arthrodesis, and reconstruction: Impact of processing techniques and study methodology. Orthopedics 1999, 22, 524–531. [Google Scholar]
  23. Han, B.; Tang, B.; Nimni, M.E. Quantitative and sensitive in vitro assay for osteoinductive activity of demineralized bone matrix. J. Orthop. Res. 2003, 21, 648–654. [Google Scholar] [CrossRef]
  24. Russell, N.; Walsh, W.R.; Lovric, V.; Kim, P.; Chen, J.H.; Larson, M.J.; Vizesi, F. In-vivo Performance of Seven Commercially Available Demineralized Bone Matrix Fiber and Putty Products in a Rat Posterolateral Fusion Model. Front. Surg. 2020, 7, 10. [Google Scholar] [CrossRef] [Green Version]
  25. Amini, A.R.; Laurencin, C.T.; Nukavarapu, S.P. Bone tissue engineering: Recent advances and challenges. Crit. Rev. Biomed Eng. 2012, 40, 363–408. [Google Scholar] [CrossRef] [Green Version]
  26. Raic, A.; Friedrich, F.; Kratzer, D.; Bieback, K.; Lahann, J.; Lee-Thedieck, C. Potential of electrospun cationic BSA fibers to guide osteogenic MSC differentiation via surface charge and fibrous topography. Sci. Rep. 2019, 9, 20003. [Google Scholar] [CrossRef]
  27. Hashemi, J.; Barati, G.; Enderami, S.E.; Safdari, M. Osteogenic Differentiation of Induced Pluripotent Stem Cells on Electrospun Nanofibers: A Review of Literature. Mater. Today Commun. 2020, 25, 101561. [Google Scholar] [CrossRef]
  28. Albrektsson, T.; Johansson, C. Osteoinduction, osteoconduction and osseointegration. Eur. Spine J. 2001, 10 (Suppl. S2), S96–S101. [Google Scholar] [CrossRef] [Green Version]
  29. Ramachandran, K.; Gouma, P.I. Electrospinning for bone tissue engineering. Recent Pat. Nanotechnol. 2008, 2, 1–7. [Google Scholar] [CrossRef]
  30. Rodrigues, M.T.; Martins, A.; Dias, I.R.; Viegas, C.A.; Neves, N.M.; Gomes, M.E.; Reis, R.L. Synergistic effect of scaffold composition and dynamic culturing environment in multilayered systems for bone tissue engineering. J. Tissue Eng. Regen. Med. 2012, 6, e24–e30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Liu, X.; Ma, P.X. Polymeric scaffolds for bone tissue engineering. Ann. Biomed Eng. 2004, 32, 477–486. [Google Scholar] [CrossRef] [PubMed]
  32. Liu, S.; Hu, C.; Ren, Z. Bone Tissue Engineering: Scaffolds with Osteoinductivity for Bone Regeneration. BioMed Res. Int. 2017, 2017, 1038476. [Google Scholar] [CrossRef] [PubMed]
  33. Hutmacher, D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21, 2529–2543. [Google Scholar] [CrossRef]
  34. Lim, D.-J. Cross-Linking Agents for Electrospinning-Based Bone Tissue Engineering. Int. J. Mol. Sci. 2022, 23, 5444. [Google Scholar] [CrossRef]
  35. Ingavle, G.C.; Leach, J.K. Advancements in electrospinning of polymeric nanofibrous scaffolds for tissue engineering. Tissue Eng. Part B Rev. 2013, 20, 277–293. [Google Scholar] [CrossRef]
  36. Shin, K.; Acri, T.; Geary, S.; Salem, A.K. Biomimetic Mineralization of Biomaterials Using Simulated Body Fluids for Bone Tissue Engineering and Regenerative Medicine. Tissue Eng. Part A 2017, 23, 1169–1180. [Google Scholar] [CrossRef]
  37. Müller, L.; Müller, F.A. Preparation of SBF with different HCO3- content and its influence on the composition of biomimetic apatites. Acta Biomater. 2006, 2, 181–189. [Google Scholar] [CrossRef]
  38. Yilmaz, B.; Evis, Z.; Tezcaner, A.; Banerjee, S. Surface Characterization and Biocompatibility of Selenium-Doped Hydroxyapatite Coating on Titanium Alloy. Int. J. Appl. Ceram. Technol. 2016, 13, 1059–1068. [Google Scholar] [CrossRef]
  39. Park, K.H.; Kim, S.-J.; Park, Y.-J.; Song, H.-J. Calcium phosphate compound formed on electrospun chitosan nanofibers using modified simulated body fluid. Polym. Bull. 2019, 76, 4205–4214. [Google Scholar] [CrossRef]
  40. Park, K.H.; Kim, S.J.; Hwang, M.J.; Song, H.J.; Park, Y.J. Biomimetic fabrication of calcium phosphate/chitosan nanohybrid composite in modified simulated body fluids. Express Polym. Lett. 2017, 11, 14–20. [Google Scholar] [CrossRef]
  41. Ghorbani, F.; Zamanian, A.; Behnamghader, A.; Joupari, M.D. Microwave-induced rapid formation of biomimetic hydroxyapatite coating on gelatin-siloxane hybrid microspheres in 10X-SBF solution. e-Polymers 2018, 18, 247–255. [Google Scholar] [CrossRef]
  42. Yilmaz, B.; Pazarceviren, A.E.; Tezcaner, A.; Evis, Z. Historical development of simulated body fluids used in biomedical applications: A review. Microchem. J. 2020, 155, 104713. [Google Scholar] [CrossRef]
  43. Olsen, B.R.; Reginato, A.M.; Wang, W. Bone Development. Annu. Rev. Cell Dev. Biol. 2000, 16, 191–220. [Google Scholar] [CrossRef]
  44. Schaffler, M.B.; Cheung, W.-Y.; Majeska, R.; Kennedy, O. Osteocytes: Master orchestrators of bone. Calcif. Tissue Int. 2014, 94, 5–24. [Google Scholar] [CrossRef] [Green Version]
  45. Florencio-Silva, R.; Sasso, G.R.d.S.; Sasso-Cerri, E.; Simões, M.J.; Cerri, P.S. Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. BioMed Res. Int. 2015, 2015, 421746. [Google Scholar] [CrossRef] [Green Version]
  46. Miller, S.C.; de Saint-Georges, L.; Bowman, B.M.; Jee, W.S. Bone lining cells: Structure and function. Scanning Microsc. 1989, 3, 953–960. [Google Scholar]
  47. Le, B.Q.; Nurcombe, V.; Cool, S.M.; Van Blitterswijk, C.A.; De Boer, J.; LaPointe, V.L.S. The Components of Bone and What They Can Teach Us about Regeneration. Materials 2018, 11, 14. [Google Scholar] [CrossRef] [Green Version]
  48. Viguet-Carrin, S.; Garnero, P.; Delmas, P.D. The role of collagen in bone strength. Osteoporos. Int. 2006, 17, 319–336. [Google Scholar] [CrossRef]
  49. Tzaphlidou, M. Bone architecture: Collagen structure and calcium/phosphorus maps. J. Biol. Phys. 2008, 34, 39–49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Rossert, J.; de Crombrugghe, B. Chapter 12—Type I Collagen: Structure, Synthesis, and Regulation. In Principles of Bone Biology, 2nd ed.; Bilezikian, J.P., Raisz, L.G., Rodan, G.A., Eds.; Academic Press: San Diego, CA, USA, 2002; pp. 189–210. [Google Scholar] [CrossRef]
  51. Tanaka, T.; Moriya, K.; Tsunenaga, M.; Yanagawa, T.; Morita, H.; Minowa, T.; Tagawa, Y.-i.; Hanagata, N.; Inagaki, Y.; Ikoma, T. Visualized procollagen Iα1 demonstrates the intracellular processing of propeptides. Life Sci. Alliance 2022, 5, e202101060. [Google Scholar] [CrossRef] [PubMed]
  52. Ramshaw, J.A.M.; Shah, N.K.; Brodsky, B. Gly-X-Y Tripeptide Frequencies in Collagen: A Context for Host–Guest Triple-Helical Peptides. J. Struct. Biol. 1998, 122, 86–91. [Google Scholar] [CrossRef] [PubMed]
  53. Cui, F.-Z.; Li, Y.; Ge, J. Self-assembly of mineralized collagen composites. Mater. Sci. Eng. R Rep. 2007, 57, 1–27. [Google Scholar] [CrossRef]
  54. Giraud Guille, M.M.; Mosser, G.; Helary, C.; Eglin, D. Bone matrix like assemblies of collagen: From liquid crystals to gels and biomimetic materials. Micron 2005, 36, 602–608. [Google Scholar] [CrossRef]
  55. Church, R.L.; Pfeiffer, S.E.; Tanzer, M.L. Collagen biosynthesis: Synthesis and secretion of a high molecular weight collagen precursor (procollagen). Proc. Natl. Acad. Sci. USA 1971, 68, 2638–2642. [Google Scholar] [CrossRef] [Green Version]
  56. Miyahara, M.; Hayashi, K.; Berger, J.; Tanzawa, K.; Njieha, F.K.; Trelstad, R.L.; Prockop, D.J. Formation of collagen fibrils by enzymic cleavage of precursors of type I collagen in vitro. J. Biol. Chem. 1984, 259, 9891–9898. [Google Scholar] [CrossRef]
  57. Holmes, D.F.; Lu, Y.; Starborg, T.; Kadler, K.E. Chapter Three—Collagen Fibril Assembly and Function. In Current Topics in Developmental Biology; Litscher, E.S., Wassarman, P.M., Eds.; Academic Press: San Diego, CA, USA, 2018; Volume 130, pp. 107–142. [Google Scholar]
  58. Chung, H.J.; Steplewski, A.; Chung, K.Y.; Uitto, J.; Fertala, A. Collagen Fibril Formation: A new target TO limit fibrosis *. J. Biol. Chem. 2008, 283, 25879–25886. [Google Scholar] [CrossRef] [Green Version]
  59. Porter, S.; Clark, I.M.; Kevorkian, L.; Edwards, D.R. The ADAMTS metalloproteinases. Biochem J. 2005, 386, 15–27. [Google Scholar] [CrossRef]
  60. Colige, A.; Vandenberghe, I.; Thiry, M.; Lambert, C.A.; Van Beeumen, J.; Li, S.-W.; Prockop, D.J.; Lapière, C.M.; Nusgens, B.V. Cloning and Characterization of ADAMTS-14, a Novel ADAMTS Displaying High Homology with ADAMTS-2 and ADAMTS-3. J. Biol. Chem. 2002, 277, 5756–5766. [Google Scholar] [CrossRef] [Green Version]
  61. Hopkins, D.R.; Keles, S.; Greenspan, D.S. The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol. 2007, 26, 508–523. [Google Scholar] [CrossRef] [Green Version]
  62. Feng, X. Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease. Curr. Chem. Biol. 2009, 3, 189–196. [Google Scholar] [CrossRef] [Green Version]
  63. Burger, C.; Zhou, H.-W.; Wang, H.; Sics, I.; Hsiao, B.S.; Chu, B.; Graham, L.; Glimcher, M.J. Lateral Packing of Mineral Crystals in Bone Collagen Fibrils. Biophys. J. 2008, 95, 1985–1992. [Google Scholar] [CrossRef] [Green Version]
  64. Flynn, A. The role of dietary calcium in bone health. Proc. Nutr. Soc. 2003, 62, 851–858. [Google Scholar] [CrossRef] [Green Version]
  65. Goretti Penido, M.; Alon, U.S. Phosphate homeostasis and its role in bone health. Pediatric Nephrol. 2012, 27, 2039–2048. [Google Scholar] [CrossRef] [Green Version]
  66. Glimcher, M.J. Chapter 2—The Nature of the Mineral Phase in Bone: Biological and Clinical Implications. In Metabolic Bone Disease and Clinically Related Disorders, 3rd ed.; Avioli, L.V., Krane, S.M., Eds.; Academic Press: San Diego, CA, USA, 1998; pp. 23–52e. [Google Scholar] [CrossRef]
  67. Koons, G.L.; Diba, M.; Mikos, A.G. Materials design for bone-tissue engineering. Nat. Rev. Mater. 2020, 5, 584–603. [Google Scholar] [CrossRef]
  68. Fratzl, P.; Gupta, H.S.; Paschalis, E.P.; Roschger, P. Structure and mechanical quality of the collagen–mineral nano-composite in bone. J. Mater. Chem. 2004, 14, 2115–2123. [Google Scholar] [CrossRef]
  69. Lin, X.; Patil, S.; Gao, Y.-G.; Qian, A. The Bone Extracellular Matrix in Bone Formation and Regeneration. Front. Pharmacol. 2020, 11, 757. [Google Scholar] [CrossRef]
  70. Hanson, D.A.; Eyre, D.R. Molecular Site Specificity of Pyridinoline and Pyrrole Cross-links in Type I Collagen of Human Bone*. J. Biol. Chem. 1996, 271, 26508–26516. [Google Scholar] [CrossRef] [Green Version]
  71. Cundy, T.; Reid, I.R.; Grey, A. CHAPTER 31—Metabolic bone disease. In Clinical Biochemistry: Metabolic and Clinical Aspects, 3rd ed.; Marshall, W.J., Lapsley, M., Day, A.P., Ayling, R.M., Eds.; Churchill Livingstone: London, UK, 2014; pp. 604–635. [Google Scholar] [CrossRef]
  72. Risteli, J.; Eriksen, H.; Risteli, L.; Mansell, J.P.; Bailey, A.J. Pyrrolic cross-links are as abundant in human bone type I collagen as pyridinolines. J. Bone Miner. Res. 1994, 9, S186. [Google Scholar]
  73. Filipowska, J.; Tomaszewski, K.A.; Niedźwiedzki, Ł.; Walocha, J.A.; Niedźwiedzki, T. The role of vasculature in bone development, regeneration and proper systemic functioning. Angiogenesis 2017, 20, 291–302. [Google Scholar] [CrossRef] [Green Version]
  74. Ott, S.M. Cortical or Trabecular Bone: What’s the Difference? Am. J. Nephrol. 2018, 47, 373–375. [Google Scholar] [CrossRef]
  75. Ascenzi, M.G.; Roe, A.K. The osteon: The micromechanical unit of compact bone. Front. Biosci. 2012, 17, 1551–1581. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Zhang, D.; Cowin, S.C.; Weinbaum, S. Electrical signal transmission and gap junction regulation in a bone cell network: A cable model for an osteon. Ann. Biomed. Eng. 1997, 25, 357–374. [Google Scholar] [CrossRef]
  77. Galea, G.L.; Zein, M.R.; Allen, S.; Francis-West, P. Making and shaping endochondral and intramembranous bones. Dev. Dyn. 2021, 250, 414–449. [Google Scholar] [CrossRef] [PubMed]
  78. Ortega, N.; Behonick, D.J.; Werb, Z. Matrix remodeling during endochondral ossification. Trends Cell Biol. 2004, 14, 86–93. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. Clarke, B. Normal Bone Anatomy and Physiology. Clin. J. Am. Soc. Nephrol. 2008, 3, S131–S139. [Google Scholar] [CrossRef] [Green Version]
  80. Hadjidakis, D.J.; Androulakis, I.I. Bone remodeling. Ann. N. Y. Acad. Sci. 2006, 1092, 385–396. [Google Scholar] [CrossRef]
  81. Schell, H.; Duda, G.N.; Peters, A.; Tsitsilonis, S.; Johnson, K.A.; Schmidt-Bleek, K. The haematoma and its role in bone healing. J. Exp. Orthop. 2017, 4, 5. [Google Scholar] [CrossRef] [Green Version]
  82. Bigham-Sadegh, A.; Oryan, A. Basic concepts regarding fracture healing and the current options and future directions in managing bone fractures. Int. Wound J. 2015, 12, 238–247. [Google Scholar] [CrossRef]
  83. Khajavi, R.; Abbasipour, M.; Bahador, A. Electrospun biodegradable nanofibers scaffolds for bone tissue engineering. J. Appl. Polym. Sci. 2016, 133, 42883. [Google Scholar] [CrossRef]
  84. Kim, S.H.; Hur, W.; Kim, J.E.; Min, H.J.; Kim, S.; Min, H.S.; Kim, B.K.; Kim, S.H.; Choi, T.H.; Jung, Y. Self-assembling peptide nanofibers coupled with neuropeptide substance P for bone tissue engineering. Tissue Eng. Part A 2015, 21, 1237–1246. [Google Scholar] [CrossRef] [Green Version]
  85. Zhao, J.; Han, W.; Chen, H.; Tu, M.; Zeng, R.; Shi, Y.; Cha, Z.; Zhou, C. Preparation, structure and crystallinity of chitosan nano-fibers by a solid–liquid phase separation technique. Carbohydr. Polym. 2011, 83, 1541–1546. [Google Scholar] [CrossRef]
  86. Yin, L.; Yang, S.; He, M.; Chang, Y.; Wang, K.; Zhu, Y.; Liu, Y.; Chang, Y.; Yu, Z. Physicochemical and biological characteristics of BMP-2/IGF-1-loaded three-dimensional coaxial electrospun fibrous membranes for bone defect repair. J. Mater. Sci. Mater. Med. 2017, 28, 94. [Google Scholar] [CrossRef]
  87. Nagiah, N.; Murdock, C.J.; Bhattacharjee, M.; Nair, L.; Laurencin, C.T. Development of Tripolymeric Triaxial Electrospun Fibrous Matrices for Dual Drug Delivery Applications. Sci. Rep. 2020, 10, 609. [Google Scholar] [CrossRef] [Green Version]
  88. Brown, T.D.; Dalton, P.D.; Hutmacher, D.W. Melt electrospinning today: An opportune time for an emerging polymer process. Prog. Polym. Sci. 2016, 56, 116–166. [Google Scholar] [CrossRef]
  89. Lian, H.; Meng, Z. Melt electrospinning vs. solution electrospinning: A comparative study of drug-loaded poly (ε-caprolactone) fibres. Mater. Sci. Eng. C 2017, 74, 117–123. [Google Scholar] [CrossRef]
  90. Fee, T.; Surianarayanan, S.; Downs, C.; Zhou, Y.; Berry, J. Nanofiber Alignment Regulates NIH3T3 Cell Orientation and Cytoskeletal Gene Expression on Electrospun PCL+Gelatin Nanofibers. PLoS ONE 2016, 11, e0154806. [Google Scholar] [CrossRef] [Green Version]
  91. Doan, T.Q.; Leslie, L.S.; Kim, S.Y.; Bhargava, R.; White, S.R.; Sottos, N.R. Characterization of core-shell microstructure and self-healing performance of electrospun fiber coatings. Polymer 2016, 107, 263–272. [Google Scholar] [CrossRef] [Green Version]
  92. Chakraborty, P.K.; Adhikari, J.; Saha, P. Facile fabrication of electrospun regenerated cellulose nanofiber scaffold for potential bone-tissue engineering application. Int. J. Biol. Macromol. 2019, 122, 644–652. [Google Scholar] [CrossRef]
  93. Karbowniczek, J.E.; Kaniuk, Ł.; Berniak, K.; Gruszczyński, A.; Stachewicz, U. Enhanced Cells Anchoring to Electrospun Hybrid Scaffolds with PHBV and HA Particles for Bone Tissue Regeneration. Front. Bioeng. Biotechnol. 2021, 9, 632029. [Google Scholar] [CrossRef]
  94. Wang, Z.; Wang, H.; Xiong, J.; Li, J.; Miao, X.; Lan, X.; Liu, X.; Wang, W.; Cai, N.; Tang, Y. Fabrication and in vitro evaluation of PCL/gelatin hierarchical scaffolds based on melt electrospinning writing and solution electrospinning for bone regeneration. Mater. Sci. Eng. C 2021, 128, 112287. [Google Scholar] [CrossRef]
  95. Xie, J.; Shen, H.; Yuan, G.; Lin, K.; Su, J. The effects of alignment and diameter of electrospun fibers on the cellular behaviors and osteogenesis of BMSCs. Mater. Sci. Eng. C 2021, 120, 111787. [Google Scholar] [CrossRef] [PubMed]
  96. Jose, M.V.; Thomas, V.; Johnson, K.T.; Dean, D.R.; Nyairo, E. Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering. Acta Biomater. 2009, 5, 305–315. [Google Scholar] [CrossRef] [PubMed]
  97. Yang, L.; Zhao, Y.; Cui, D.; Liu, Y.; Zou, Q.; Xu, S.; Luo, S.; Ye, C. Coaxial bioelectrospinning of P34HB/PVA microfibers biomimetic scaffolds with simultaneity cell-laden for improving bone regeneration. Mater. Des. 2022, 213, 110349. [Google Scholar] [CrossRef]
  98. Panzavolta, S.; Gualandi, C.; Fiorani, A.; Bracci, B.; Focarete, M.L.; Bigi, A. Fast Coprecipitation of Calcium Phosphate Nanoparticles inside Gelatin Nanofibers by Tricoaxial Electrospinning. J. Nanomater. 2016, 2016, 4235235. [Google Scholar] [CrossRef] [Green Version]
  99. Udomluck, N.; Koh, W.-G.; Lim, D.-J.; Park, H. Recent Developments in Nanofiber Fabrication and Modification for Bone Tissue Engineering. Int. J. Mol. Sci. 2020, 21, 99. [Google Scholar] [CrossRef] [Green Version]
  100. Xue, J.; Wu, T.; Dai, Y.; Xia, Y. Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications. Chem. Rev. 2019, 119, 5298–5415. [Google Scholar] [CrossRef]
  101. Prabhakaran, M.P.; Venugopal, J.; Ramakrishna, S. Electrospun nanostructured scaffolds for bone tissue engineering. Acta Biomater. 2009, 5, 2884–2893. [Google Scholar] [CrossRef]
  102. Hu, Y.; Grainger, D.W.; Winn, S.R.; Hollinger, J.O. Fabrication of poly(α-hydroxy acid) foam scaffolds using multiple solvent systems. J. Biomed. Mater. Res. 2002, 59, 563–572. [Google Scholar] [CrossRef]
  103. Yoshimoto, H.; Shin, Y.M.; Terai, H.; Vacanti, J.P. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 2003, 24, 2077–2082. [Google Scholar] [CrossRef]
  104. Sahoo, S.; Ang, L.T.; Goh, J.C.-H.; Toh, S.-L. Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications. J. Biomed. Mater. Res. Part A 2010, 93A, 1539–1550. [Google Scholar] [CrossRef]
  105. Zhang, B.; Yan, X.; He, H.-W.; Yu, M.; Ning, X.; Long, Y.-Z. Solvent-free electrospinning: Opportunities and challenges. Polym. Chem. 2017, 8, 333–352. [Google Scholar] [CrossRef]
  106. Kim, B.S.; Park, K.E.; Kim, M.H.; You, H.K.; Lee, J.; Park, W.H. Effect of nanofiber content on bone regeneration of silk fibroin/poly(ε-caprolactone) nano/microfibrous composite scaffolds. Int. J. Nanomed. 2015, 10, 485–502. [Google Scholar] [CrossRef]
  107. Saidy, N.T.; Shabab, T.; Bas, O.; Rojas-González, D.M.; Menne, M.; Henry, T.; Hutmacher, D.W.; Mela, P.; De-Juan-Pardo, E.M. Melt Electrowriting of Complex 3D Anatomically Relevant Scaffolds. Front. Bioeng. Biotechnol. 2020, 8. [Google Scholar] [CrossRef]
  108. McColl, E.; Groll, J.; Jungst, T.; Dalton, P.D. Design and fabrication of melt electrowritten tubes using intuitive software. Mater. Des. 2018, 155, 46–58. [Google Scholar] [CrossRef]
  109. Abdal-hay, A.; Abbasi, N.; Gwiazda, M.; Hamlet, S.; Ivanovski, S. Novel polycaprolactone/hydroxyapatite nanocomposite fibrous scaffolds by direct melt-electrospinning writing. Eur. Polym. J. 2018, 105, 257–264. [Google Scholar] [CrossRef] [Green Version]
  110. Wang, K.; Liu, L.; Xie, J.; Shen, L.; Tao, J.; Zhu, J. Facile Strategy to Generate Aligned Polymer Nanofibers: Effects on Cell Adhesion. ACS Appl. Mater. Interfaces 2018, 10, 1566–1574. [Google Scholar] [CrossRef]
  111. Vogel, V.; Sheetz, M. Local force and geometry sensing regulate cell functions. Nat. Rev. Mol. Cell Biol. 2006, 7, 265–275. [Google Scholar] [CrossRef]
  112. Wang, B.; Cai, Q.; Zhang, S.; Yang, X.; Deng, X. The effect of poly (L-lactic acid) nanofiber orientation on osteogenic responses of human osteoblast-like MG63 cells. J. Mech. Behav. Biomed. Mater. 2011, 4, 600–609. [Google Scholar] [CrossRef]
  113. Reible, B.; Schmidmaier, G.; Prokscha, M.; Moghaddam, A.; Westhauser, F. Continuous stimulation with differentiation factors is necessary to enhance osteogenic differentiation of human mesenchymal stem cells in-vitro. Growth Factors 2017, 35, 179–188. [Google Scholar] [CrossRef]
  114. Gregory, C.A.; Grady Gunn, W.; Peister, A.; Prockop, D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: Comparison with cetylpyridinium chloride extraction. Anal. Biochem. 2004, 329, 77–84. [Google Scholar] [CrossRef]
  115. Matthews, J.A.; Wnek, G.E.; Simpson, D.G.; Bowlin, G.L. Electrospinning of Collagen Nanofibers. Biomacromolecules 2002, 3, 232–238. [Google Scholar] [CrossRef]
  116. Wu, Y.; Carnell, L.A.; Clark, R.L. Control of electrospun mat width through the use of parallel auxiliary electrodes. Polymer 2007, 48, 5653–5661. [Google Scholar] [CrossRef]
  117. Li, D.; Wang, Y.; Xia, Y. Electrospinning of Polymeric and Ceramic Nanofibers as Uniaxially Aligned Arrays. Nano Lett. 2003, 3, 1167–1171. [Google Scholar] [CrossRef]
  118. Katta, P.; Alessandro, M.; Ramsier, R.D.; Chase, G.G. Continuous Electrospinning of Aligned Polymer Nanofibers onto a Wire Drum Collector. Nano Lett. 2004, 4, 2215–2218. [Google Scholar] [CrossRef]
  119. Afifi, A.M.; Nakajima, H.; Yamane, H.; Kimura, Y.; Nakano, S. Fabrication of Aligned Poly(L-lactide) Fibers by Electrospinning and Drawing. Macromol. Mater. Eng. 2009, 294, 658–665. [Google Scholar] [CrossRef]
  120. Ajao, J.A.; Abiona, A.A.; Chigome, S.; Fasasi, A.Y.; Osinkolu, G.A.; Maaza, M. Electric-magnetic field-induced aligned electrospun poly (ethylene oxide) (PEO) nanofibers. J. Mater. Sci. 2010, 45, 2324–2329. [Google Scholar] [CrossRef]
  121. Kancheva, M.; Toncheva, A.; Manolova, N.; Rashkov, I. Advanced centrifugal electrospinning setup. Mater. Lett. 2014, 136, 150–152. [Google Scholar] [CrossRef]
  122. Ma, J.; He, X.; Jabbari, E. Osteogenic differentiation of marrow stromal cells on random and aligned electrospun poly(L-lactide) nanofibers. Ann. Biomed Eng. 2011, 39, 14–25. [Google Scholar] [CrossRef]
  123. Delaine-Smith, R.M.; Hann, A.J.; Green, N.H.; Reilly, G.C. Electrospun Fiber Alignment Guides Osteogenesis and Matrix Organization Differentially in Two Different Osteogenic Cell Types. Front. Bioeng. Biotechnol. 2021, 9. [Google Scholar] [CrossRef]
  124. Moghe, A.K.; Gupta, B.S. Co-axial Electrospinning for Nanofiber Structures: Preparation and Applications. Polym. Rev. 2008, 48, 353–377. [Google Scholar] [CrossRef]
  125. Han, D.; Steckl, A.J. Triaxial Electrospun Nanofiber Membranes for Controlled Dual Release of Functional Molecules. ACS Appl. Mater. Interfaces 2013, 5, 8241–8245. [Google Scholar] [CrossRef] [PubMed]
  126. Lu, Y.; Huang, J.; Yu, G.; Cardenas, R.; Wei, S.; Wujcik, E.K.; Guo, Z. Coaxial electrospun fibers: Applications in drug delivery and tissue engineering. WIREs Nanomed. Nanobiotechnology 2016, 8, 654–677. [Google Scholar] [CrossRef] [PubMed]
  127. Kareem, M.M.; Hodgkinson, T.; Sanchez, M.S.; Dalby, M.J.; Tanner, K.E. Hybrid core–shell scaffolds for bone tissue engineering. Biomed. Mater. 2019, 14, 025008. [Google Scholar] [CrossRef] [PubMed]
  128. Shao, W.; He, J.; Sang, F.; Ding, B.; Chen, L.; Cui, S.; Li, K.; Han, Q.; Tan, W. Coaxial electrospun aligned tussah silk fibroin nanostructured fiber scaffolds embedded with hydroxyapatite-tussah silk fibroin nanoparticles for bone tissue engineering. Mater. Sci. Eng. C Mater. Biol. Appl. 2016, 58, 342–351. [Google Scholar] [CrossRef]
  129. Asli, M.M.; Pourdeyhimi, B.; Loboa, E.G. Release Profiles of Tricalcium Phosphate Nanoparticles from Poly(L-lactic acid) Electrospun Scaffolds with Single Component, Core–Sheath, or Porous Fiber Morphologies: Effects on hASC Viability and Osteogenic Differentiation. Macromol. Biosci. 2012, 12, 893–900. [Google Scholar] [CrossRef]
  130. Nair, A.K.; Gautieri, A.; Chang, S.-W.; Buehler, M.J. Molecular mechanics of mineralized collagen fibrils in bone. Nat. Commun. 2013, 4, 1724. [Google Scholar] [CrossRef] [Green Version]
  131. Kokubo, T. Bioactive glass ceramics: Properties and applications. Biomaterials 1991, 12, 155–163. [Google Scholar] [CrossRef]
  132. Kokubo, T.; Kushitani, H.; Sakka, S.; Kitsugi, T.; Yamamuro, T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W3. J. Biomed. Mater. Res. 1990, 24, 721–734. [Google Scholar] [CrossRef]
  133. Lee, J.T.Y.; Leng, Y.; Chow, K.L.; Ren, F.; Ge, X.; Wang, K.; Lu, X. Cell culture medium as an alternative to conventional simulated body fluid. Acta Biomater. 2011, 7, 2615–2622. [Google Scholar] [CrossRef]
  134. Oyane, A.; Onuma, K.; Ito, A.; Kim, H.M.; Kokubo, T.; Nakamura, T. Formation and growth of clusters in conventional and new kinds of simulated body fluids. J. Biomed. Mater. Research. Part A 2003, 64, 339–348. [Google Scholar] [CrossRef]
  135. Takadama, H.; Hashimoto, M.; Mizuno, M.; Kunio, I.; Kokubo, T. Newly Improved Simulated Body Fluid. Key Eng. Mater. 2004, 254–256, 115–118. [Google Scholar] [CrossRef]
  136. Zvicer, J.; Medic, A.; Veljovic, D.; Jevtic, S.; Novak, S.; Obradovic, B. Biomimetic characterization reveals enhancement of hydroxyapatite formation by fluid flow in gellan gum and bioactive glass composite scaffolds. Polym. Test. 2019, 76, 464–472. [Google Scholar] [CrossRef]
  137. Yu, H.-S.; Jang, J.-H.; Kim, T.-I.; Lee, H.-H.; Kim, H.-W. Apatite-mineralized polycaprolactone nanofibrous web as a bone tissue regeneration substrate. J. Biomed. Mater. Res. Part A 2009, 88A, 747–754. [Google Scholar] [CrossRef]
  138. Wang, D.; Christensen, K.; Chawla, K.; Xiao, G.; Krebsbach, P.H.; Franceschi, R.T. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J. Bone Miner. Res. 1999, 14, 893–903. [Google Scholar] [CrossRef]
  139. Belgheisi, G.; Nazarpak, M.H.; Hashjin, M.S. Bone tissue engineering electrospun scaffolds based on layered double hydroxides with the ability to release vitamin D3: Fabrication, characterization and in vitro study. Appl. Clay Sci. 2020, 185, 105434. [Google Scholar] [CrossRef]
  140. Andric, T.; Wright, L.D.; Freeman, J.W. Rapid Mineralization of Electrospun Scaffolds for Bone Tissue Engineering. J. Biomater. Sci. Polym. Ed. 2011, 22, 1535–1550. [Google Scholar] [CrossRef]
  141. Fu, Q.W.; Zi, Y.P.; Xu, W.; Zhou, R.; Cai, Z.Y.; Zheng, W.J.; Chen, F.; Qian, Q.R. Electrospinning of calcium phosphate-poly (d,l-lactic acid) nanofibers for sustained release of water-soluble drug and fast mineralization. Int. J. Nanomed. 2016, 11, 5087–5097. [Google Scholar] [CrossRef] [Green Version]
  142. Boda, S.K.; Almoshari, Y.; Wang, H.; Wang, X.; Reinhardt, R.A.; Duan, B.; Wang, D.; Xie, J. Mineralized nanofiber segments coupled with calcium-binding BMP-2 peptides for alveolar bone regeneration. Acta Biomater. 2019, 85, 282–293. [Google Scholar] [CrossRef]
  143. Wang, D.; Jang, J.; Kim, K.; Kim, J.; Park, C.B. “Tree to Bone”: Lignin/Polycaprolactone Nanofibers for Hydroxyapatite Biomineralization. Biomacromolecules 2019, 20, 2684–2693. [Google Scholar] [CrossRef]
  144. Ataie, M.; Shabani, I.; Seyedjafari, E. Surface mineralized hybrid nanofibrous scaffolds based on poly(l-lactide) and alginate enhances osteogenic differentiation of stem cells. J. Biomed. Mater. Res. Part A 2019, 107, 586–596. [Google Scholar] [CrossRef]
  145. Nie, D.; Luo, Y.; Li, G.; Jin, J.; Yang, S.; Li, S.; Zhang, Y.; Dai, J.; Liu, R.; Zhang, W. The Construction of Multi-Incorporated Polylactic Composite Nanofibrous Scaffold for the Potential Applications in Bone Tissue Regeneration. Nanomaterials 2021, 11, 2402. [Google Scholar] [CrossRef]
  146. Rajzer, I.; Menaszek, E.; Kwiatkowski, R.; Chrzanowski, W. Bioactive nanocomposite PLDL/nano-hydroxyapatite electrospun membranes for bone tissue engineering. J. Mater. Sci. Mater. Med. 2014, 25, 1239–1247. [Google Scholar] [CrossRef] [Green Version]
  147. Kanjwal, M.A.; Sheikh, F.A.; Nirmala, R.; Macossay, J.; Kim, H.Y. Fabrication of poly(caprolactone) nanofibers containing hydroxyapatite nanoparticles and their mineralization in a simulated body fluid. Fibers Polym. 2011, 12, 50–56. [Google Scholar] [CrossRef]
  148. Guo, Y.; Lan, J.; Zhang, C.; Cao, M.; Cai, Q.; Yang, X. Mineralization on polylactide/gelatin composite nanofibers using simulated body fluid containing amino acid. Appl. Surf. Sci. 2015, 349, 538–548. [Google Scholar] [CrossRef]
  149. Jie, Y.; Cai, Z.; Li, S.; Xie, Z.; Ma, M.; Huang, X. Hydroxyapatite nucleation and growth on collagen electrospun fibers controlled with different mineralization conditions and phosvitin. Macromol. Res. 2017, 25, 905–912. [Google Scholar] [CrossRef]
  150. Yilmaz, B.; Ağagündüz, D. Bioactivities of hen’s egg yolk phosvitin and its functional phosphopeptides in food industry and health. J. Food Sci. 2020, 85, 2969–2976. [Google Scholar] [CrossRef]
  151. Lao, L.; Zhu, Y.; Zhang, Y.; Gao, Z.; Zhou, F.; Chen, L.; Ouyang, H.; Gao, C. Mineralization of Collagen-Coated Electrospun Poly(lactide-co-glycolide) Nanofibrous Mesh to Enhance Growth and Differentiation of Osteoblasts and Bone Marrow Mesenchymal Stem Cells. Adv. Eng. Mater. 2012, 14, B123–B137. [Google Scholar] [CrossRef]
  152. Chahal, S.; Fathima, S.J.H.; Yusoff, M.B.M. Biomimetic growth of bone-like apatite via simulated body fluid on hydroxyethyl cellulose/polyvinyl alcohol electrospun nanofibers. Bio-Med. Mater. Eng. 2014, 24, 799–806. [Google Scholar] [CrossRef] [Green Version]
  153. Ercan, B.; Webster, T.J. Greater osteoblast proliferation on anodized nanotubular titanium upon electrical stimulation. Int. J. Nanomed. 2008, 3, 477–485. [Google Scholar] [CrossRef] [Green Version]
  154. Ferrier, J.; Ross, S.M.; Kanehisa, J.; Aubin, J.E. Osteoclasts and osteoblasts migrate in opposite directions in response to a constant electrical field. J. Cell. Physiol. 1986, 129, 283–288. [Google Scholar] [CrossRef]
  155. Samadian, H.; Mobasheri, H.; Hasanpour, S.; Ai, J.; Azamie, M.; Faridi-Majidi, R. Electro-conductive carbon nanofibers as the promising interfacial biomaterials for bone tissue engineering. J. Mol. Liq. 2020, 298, 112021. [Google Scholar] [CrossRef]
  156. Samadian, H.; Mobasheri, H.; Azami, M.; Faridi-Majidi, R. Osteoconductive and electroactive carbon nanofibers/hydroxyapatite nanocomposite tailored for bone tissue engineering: In vitro and in vivo studies. Sci. Rep. 2020, 10, 14853. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Schematic image of bone anatomy. Reprinted with permission from Ref. [47]. Copyright 2017 MDPI. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Figure 1. Schematic image of bone anatomy. Reprinted with permission from Ref. [47]. Copyright 2017 MDPI. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Polymers 14 02123 g001
Figure 2. Schematic images of different electrospun fabrication techniques: (a) monoaxial electrospinning; (b) melt electrospinning; (c) aligned electrospinning; (d) coaxial electrospinning. (a,b) reproduced with permission from Ref. [89]. Copyright 2017 Elsevier; (c) reproduced with permission from Ref. [90]. Copyright 2016 PLOS under a Creative Commons Attribution 4.0 International License; (d) reproduced with permission from Ref. [91]. Copyright 2016 Elsevier. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Figure 2. Schematic images of different electrospun fabrication techniques: (a) monoaxial electrospinning; (b) melt electrospinning; (c) aligned electrospinning; (d) coaxial electrospinning. (a,b) reproduced with permission from Ref. [89]. Copyright 2017 Elsevier; (c) reproduced with permission from Ref. [90]. Copyright 2016 PLOS under a Creative Commons Attribution 4.0 International License; (d) reproduced with permission from Ref. [91]. Copyright 2016 Elsevier. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Polymers 14 02123 g002
Figure 3. Scanning electron microscope images of as-prepared scaffolds and after 3 and 7 days incubation in 10× SBF. The formation of spherical apatite-like crystals increased significantly after adding nanohybrids to the scaffolds. For the legends, pure PCL and VD3·LDH/PCL electrospun scaffolds containing 1.25, 2.5, and 5 wt% of vitamin D3 are presented as PCL, 1.25VL/P, 2.5VL/P, and 5VL/P, respectively. Reprinted with permission from Ref. [139]. Copyright 2020 Elsevier. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Figure 3. Scanning electron microscope images of as-prepared scaffolds and after 3 and 7 days incubation in 10× SBF. The formation of spherical apatite-like crystals increased significantly after adding nanohybrids to the scaffolds. For the legends, pure PCL and VD3·LDH/PCL electrospun scaffolds containing 1.25, 2.5, and 5 wt% of vitamin D3 are presented as PCL, 1.25VL/P, 2.5VL/P, and 5VL/P, respectively. Reprinted with permission from Ref. [139]. Copyright 2020 Elsevier. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Polymers 14 02123 g003
Figure 4. Scanning electron microscope images of the gradual deposition of minerals onto PLLA/gelatin composite nanofibers over time in different concentrated SBF (2.5×) fortified with amino acids (2.5 mM) at 37 ± 0.2 °C. The numbers following the alphabets a–d indicate the soaking time (days). (a1a3,a5,a7) 2.5 SBF-blank; (b1b3,b5,b7) 2.5 SBF-Gly; (c1c3,c5,c7) 2.5 SBF-Arg; (d1d3,d5,d7) 2.5 SBF-Asp. The number shown in each panel of the figure represents the days of each SBF treatment. Magnification of 1000×. Reprinted with permission from Ref. [148]. Copyright 2015 Elsevier. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Figure 4. Scanning electron microscope images of the gradual deposition of minerals onto PLLA/gelatin composite nanofibers over time in different concentrated SBF (2.5×) fortified with amino acids (2.5 mM) at 37 ± 0.2 °C. The numbers following the alphabets a–d indicate the soaking time (days). (a1a3,a5,a7) 2.5 SBF-blank; (b1b3,b5,b7) 2.5 SBF-Gly; (c1c3,c5,c7) 2.5 SBF-Arg; (d1d3,d5,d7) 2.5 SBF-Asp. The number shown in each panel of the figure represents the days of each SBF treatment. Magnification of 1000×. Reprinted with permission from Ref. [148]. Copyright 2015 Elsevier. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Polymers 14 02123 g004
Figure 5. Scanning electron microscope (SEM) images of pristine carbon nanofibers (P-CNFs) and pre-treated carbon nanofibers (T-CNFs) incubated in a normal SBF. (a) T-CNFs-12 h, (b) T-CNFs-24 h, (c) T-CNFs-48 h, (d) T-CNFs-72 h, (e) P-CNFs-12 h, (f) P-CNFs-24, (g) P-CNFs-48 h, and (h) P-CNFs-72 h. (i,j) 3D computed tomography (CT) imaging of in vivo repair of a defective femur via mineralized carbon nanofibers (M-CNFs). Diagnostic 3D imaging (CT scan) of femur bone defects after 8 weeks of injury. The arrow shows the unrepaired defective site in the control group (i) and the bone defect repaired by normal tissue growth caused by the M-CNFs (j). Reprinted with permission from Ref. [156]. Copyright 2020 Nature publishing group. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Figure 5. Scanning electron microscope (SEM) images of pristine carbon nanofibers (P-CNFs) and pre-treated carbon nanofibers (T-CNFs) incubated in a normal SBF. (a) T-CNFs-12 h, (b) T-CNFs-24 h, (c) T-CNFs-48 h, (d) T-CNFs-72 h, (e) P-CNFs-12 h, (f) P-CNFs-24, (g) P-CNFs-48 h, and (h) P-CNFs-72 h. (i,j) 3D computed tomography (CT) imaging of in vivo repair of a defective femur via mineralized carbon nanofibers (M-CNFs). Diagnostic 3D imaging (CT scan) of femur bone defects after 8 weeks of injury. The arrow shows the unrepaired defective site in the control group (i) and the bone defect repaired by normal tissue growth caused by the M-CNFs (j). Reprinted with permission from Ref. [156]. Copyright 2020 Nature publishing group. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Polymers 14 02123 g005
Table 1. Recent examples of using simulated body fluids (SBFs) in different applications 1.
Table 1. Recent examples of using simulated body fluids (SBFs) in different applications 1.
NameFold-Change 2DescriptionsPurposeImplications
HCO 3 modified SBF [37]1-fold HCO 3 ions were incrementally supplemented.
(5, 10, 15, 20, and 27 mM)
Addition of HCO 3 ions affected the composition and structure of formed calcium phosphates.Under conditions lower than 20 mM, only B-type carbonated apatite precipitated, while 27 mM HCO 3 resulted in the formation of A-type carbonated apatite as well.
Selenate added 1.5× SBF [38]1.5-fold0.15 mM SeO42− ion was added, and ion concentration was increased to 1.5×.
Subtractions: None
Incorporating Se into the bone-like apatite structure to obtain a coating with potential anti-cancer and anti-bacterial properties on the surface of Ti6Al4V.Adding 0.15 mM selenate ion did not yield secondary calcium phosphate phases other than HA. Se was shown to inhibit the proliferation of osteosarcoma cells without affecting the proliferation of normal bone cells in vitro. The coating was also shown to inhibit the growth of Staphylococcus epidermidis.
Modified SBF [39]2-foldConcentrations of CaCl2 and KH2PO4 were doubled.
Subtractions: None
Deposition of CaP 4 onto electrospun chitosan and polyvinyl alcohol (PVA) fibersSpherical CaP crystallites (average diameter of 350 nm) with nano-sized β-TCP 5 crystalline plates with low crystallinity formed on the fibers starting from the first day.
Modified SBF [40]2-foldConcentrations of CaCl2 and KH2PO4 were doubled.
Subtractions: None
Deposition of CaP on chitosan substrates, which were prepared by spin coating of chitosan on TiMg ion-incorporated bone-like apatite was synthesized by incubating the chitosan-coated Ti in m-SBF.
10× SBF
[41]
10-foldIon concentration was increased to 10×.
Subtractions: HCO 3 and SO42− ions were omitted. No buffering agent was used.
The formation of HA 3 onto gelatin-siloxane microspheres was fabricated via a single emulsion method in modified 10× SBF solution using microwave energy (600 W).The homogeneity and speed of mineralization increased in 10× SBF solution with the microwave-assisted method, compared to the conventional coating systems. Biomimetic monodispersed HA exhibited nanoscale morphology and good cytocompatibility with human osteosarcoma cell lines (MG-63).
Boron added SBF (B-SBF)
[42]
10-fold5–17 mg boric acid (H3BO3) was added, and the ion concentration was increased to 10×.
Subtractions: HCO 3 and SO42− ions were omitted. No buffering agent was used.
Producing biomimetic boron-doped HA with the support of microwave for coating tissue scaffoldsFreeze-dried chitosan tissue scaffolds were coated with boron-doped HA via the microwave-assisted biomimetic process. No buffers were used in the preparation of 10× SBF. The addition of boron did not alter the crystallinity of HA.
1 This table is a revised version from the original table in Ref. [42] with permission. Copyright 2020 Elsevier. 2 Fold-changes were estimated based on the concentration with respect to [Ca2+] in the conventional SBF (c-SBF) formulation. 3 Hydroxyapatite (HA); 4 Calcium phosphate (CaP); 5 β-tricalcium phosphates (β-TCP).
Table 2. A comparison of different modes of electrospinning (ES) for bone regeneration 1.
Table 2. A comparison of different modes of electrospinning (ES) for bone regeneration 1.
ES ModesAdvantagesLimitationsRecent Examples
MonoaxialSimple installation
Easy to operate
Random patterns
Lack of tensile strength
Regenerated cellulose non-woven electrospun scaffolds [92]
HA-embedded poly(3-hydroxybutyric acid-co-3-hydrovaleric acid) (PHBV) random nanofibers [93]
MeltThree-dimensional structure
Larger pore size
Diverse diameter range
Eco-friendly method
Expensive setup
Mostly amorphous fibers and thermal degradation
Multilayered PCL/
gelatin scaffolds (through both monoaxial and melt modes) [94]
AlignedAligned structure
Guided oriented arrangement and elongation of cells
Decreased size in diameter
Good mechanical properties
Complex setup
Clogging or jet instability
Aligned poly (L-lactic acids) (PLLA) nanofibers [95]
Aligned nano-HA-incorporated poly(D,L-lactide-co-glycolide) (PLGA) electrospun scaffolds [96]
Multi-AxialCore-shell structure
Versatility and flexibility for functional scaffolds
Complex setup
Difficult material selection and fabrication
Coaxial poly (3-hydroxybutyrate-co-4-hydroxybutyrate)/poly (vinyl alcohol) (P34HB/PVA) nanofibers [97]
Triaxially in-situ calcium phosphate fabrication in gelatin electrospun nanofibers [98]
1 This table is a revised version of the original table in Ref. [99]. Copyright 2020 MDPI. More details on “Copyright and Licensing” are available via the following link: https://www.mdpi.com/ethics#10, accessed on 15 April 2022.
Table 3. Formulations of various simulated body fluids (SBFs).
Table 3. Formulations of various simulated body fluids (SBFs).
Ions (mM)Blood Plasma
TotalDissociatedc-SBFr-SBFi-SBFm-SBFn-SBF
Na+142.0142.0142.0142.0142.0142.0142.0
K+5.05.05.05.05.05.05.0
Mg2+1.51.01.51.51.01.51.5
Ca2+2.51.32.52.51.62.52.5
Cl103.0103.0147.8103.0103.0103.0103.0
HCO327.027.04.227.027.010.04.2
HPO42−1.01.01.01.01.01.01.0
SO42−0.50.50.50.50.50.50.5
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lim, D.-J. Bone Mineralization in Electrospun-Based Bone Tissue Engineering. Polymers 2022, 14, 2123. https://doi.org/10.3390/polym14102123

AMA Style

Lim D-J. Bone Mineralization in Electrospun-Based Bone Tissue Engineering. Polymers. 2022; 14(10):2123. https://doi.org/10.3390/polym14102123

Chicago/Turabian Style

Lim, Dong-Jin. 2022. "Bone Mineralization in Electrospun-Based Bone Tissue Engineering" Polymers 14, no. 10: 2123. https://doi.org/10.3390/polym14102123

APA Style

Lim, D. -J. (2022). Bone Mineralization in Electrospun-Based Bone Tissue Engineering. Polymers, 14(10), 2123. https://doi.org/10.3390/polym14102123

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop